Navigation Links
‘Path to 2025’ Alzheimer’s Disease Summit: Reforms Urgently Needed to Streamline Road to Alzheimer’s Prevention and Treatment as Global Prevalence is Set to Triple
Date:11/6/2013

ent Currently Three Times Industry Average

One of the significant findings in the report is that the major bottlenecks in identifying an effective Alzheimer’s disease treatment are the high cost and risk of drug development and research, particularly large clinical trials of thousands of patients over multiple years that test a single drug. The report estimates that the total cost of bringing an effective Alzheimer’s treatment to market currently approaches $6 billion – nearly three times the industry average for drug development. (Total cost includes expenditures on an effective drug and on the failed drugs preceding it.)

The report considers the likely economic impacts of adopting a series of recommendations made by government agencies, expert panels, and other bodies to streamline how Alzheimer’s drugs are developed and tested. Among the reforms recommended are:

  • Developing reliable disease markers to predict the progression of Alzheimer’s disease in different patients and better match people with treatments likely to work for them;
  • Making clinical trials more efficient and less costly by establishing global trial-ready cohorts of eligible clinical trial participants as well as using adaptive trial designs that will enable the testing of multiple drugs, in combination, tailored for different at-risk populations;
  • Establishing data-sharing arrangements for companies to share precompetitive research results so that other scientists can learn more rapidly how to slow or stop Alzheimer’s; and
  • Promoting public-private partnerships that pool resources from governments, academia, industry, and patient advocates to co-invest in Alzheimer’s drug development and testing.

The report estimates that implementing these and other reforms to Alzheimer’s drug development would reduce the total cost of developing an effective Alzheimer’s treatment by nearly
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. The Alzheimer’s Caregiver™ Offers a New Educational Concept of Care That Bridges the Gap between Research and Caregiving
2. The Alzheimer’s Caregiver™ - Bridges the Gap between Research and Care
3. National League for Nursing to Create Alzheimer’s Curricula and Resources for Nurse Educators
4. Physicians Group Calls on the FDA to Repurpose Enbrel for the Treatment of TBI, Stroke and Alzheimer’s Disease
5. The Alzheimer’s Epidemic Is Coming. How Can The National Association of Professional Geriatric Care Managers Help Prepare Families?
6. WOW Memories Announces New Efforts to Help Support Alzheimer’s Charity Events
7. Minocycline Enhances the Efficacy of Perispinal Enbrel in Traumatic Brain Injury Treatment as well as Stroke Treatment and Alzheimer’s Treatment
8. Breakthrough Drug MW151 Emerges as a Potential Competitor to Perispinally Administered Etanercept Inducing Rapid Recovery of Functions Lost to Alzheimer’s, Stroke and TBI
9. New Study from AAN: Herpes May Lead to Alzheimer’s Disease; polyDNA Recommends Gene-Eden-VIR Against the Herpes Virus
10. Living Well Assisted Living at Home Hosts Ongoing Support Group for Patients with Early Onset Alzheimer’s
11. New Study Links Air Pollution to Alzheimer’s Disease -- Says Cure Alzheimer's Fund
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 20, 2014 BCC Research ( ... PHOTONIC SENSORS AND DETECTORS: TECHNOLOGIES AND GLOBAL MARKETS ... is expected to grow to $15.2 billion by ... (CAGR) of 15.9%. Increasing industrialization is driving ... a rapidly expanding range of industrial applications such ...
(Date:8/20/2014)... A Missouri federal judge has remanded a lawsuit filed ... GranuFlo and NaturaLyte to the City of St. Louis Circuit ... The judge rejected an assertion by the defendants that the ... et al. v. Fresenius Medical Care North America Inc., et ... the manufacturer of the dialysis products GranuFlo and NaturaLyte. In ...
(Date:8/20/2014)... (HealthDay News) -- Leaving the car at home and getting ... for your health, a new study indicates. Researchers looked ... that 76 percent of men and 72 percent of women ... of women used public transit, and 14 percent of men ... who drove to work weighed more and had higher levels ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 The ... leading nonprofit authority on the use of health ... announced the full agenda for its annual fall ... IT Efficiency. WEDI-Con 2014 will take place at ... 20-23, 2014, attracting a diverse cross-section of payers, ...
(Date:8/20/2014)... Parents and kids across the nation are ... means buying textbooks and arranging after school care, there ... part of the annual re-commitment to your child’s education; ... Association, 27% of students say they experience "extreme stress" ... are stressed by school pressures. The study, Stress in ...
Breaking Medicine News(10 mins):Health News:Global Market for Photonic Sensors and Detectors to Reach $15.2 Billion in 2019 2Health News:Global Market for Photonic Sensors and Detectors to Reach $15.2 Billion in 2019 3Health News:GranuFlo/NaturaLyte Case Remanded to State Court By Missouri Federal Judge, Baron and Budd Reports 2Health News:Want to Stay Slim? Leave the Car at Home 2Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 2Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 3Health News:Five Easy Steps to Help Your Child Manage Back-to-school Stress 2Health News:Five Easy Steps to Help Your Child Manage Back-to-school Stress 3
... Resuscitating hopelessly ill patients too slowly to save their ... prolongs death and suffering, according to the November issue ... Jacinta Kelly, from Trinity College Dublin, has called for ... the practice of slow codes and highlighted the need ...
... Ellex Medical Lasers,Limited (ASX: ELX), a global leader ... ultrasound systems, announced today that the initial,results of ... be presented by Peter Hamilton MD, FRCOph at ... which takes place,November 10-13, in New Orleans. Dr. ...
... Amira Pharmaceuticals, a small,molecule pharmaceutical company focused on ... disease linked to the eicosanoid pathway,today announced the ... development. Dr. Raizon-Ounis brings 20 years of ... clinical research & licensing executive with,Roche Palo Alto. ...
... convenience for on-the-go snacking, COLUMBUS, Ohio, ... ),today announced the launch of new Fruitified(TM) ... four,great-tasting flavors: Apple Cinnamon, Blueberry, Banana Nut ... an excellent source of,protein and calcium and ...
... play role in autism, asthma,and other chronic health ... National Autism,Association (NAA) announced today a nationwide initiative ... program created by,the Deirdre Imus Environmental Center for ... to eliminate the serious,dangers posed to children from ...
... to the Third Quarter of 2006- ... During the Quarter-, PRINCETON, N.J., Nov. 1 Orchid ... identity DNA testing,services, today reported its financial results for the ... the third quarter of 2007,compared to $15.7 million for the ...
Cached Medicine News:Health News:Token resuscitation attempts on hopelessly ill patients prolong suffering 2Health News:Token resuscitation attempts on hopelessly ill patients prolong suffering 3Health News:Ellex Announces New Retina Regeneration Therapy to be Presented at the AAO 2Health News:Ellex Announces New Retina Regeneration Therapy to be Presented at the AAO 3Health News:Ellex Announces New Retina Regeneration Therapy to be Presented at the AAO 4Health News:Amira Pharmaceuticals Appoints First Vice President of Development 2Health News:Abbott Launches Fruitified(TM) ZonePerfect(R) All-Natural Nutrition Bars 2Health News:Abbott Launches Fruitified(TM) ZonePerfect(R) All-Natural Nutrition Bars 3Health News:National Autism Association and Deirdre Imus Environmental Center for Pediatric Oncology Announce National 'Greening Your School' Initiative 2Health News:Orchid Cellmark Reports Third Quarter 2007 Financial Results 2Health News:Orchid Cellmark Reports Third Quarter 2007 Financial Results 3Health News:Orchid Cellmark Reports Third Quarter 2007 Financial Results 4Health News:Orchid Cellmark Reports Third Quarter 2007 Financial Results 5Health News:Orchid Cellmark Reports Third Quarter 2007 Financial Results 6Health News:Orchid Cellmark Reports Third Quarter 2007 Financial Results 7
(Date:8/19/2014)... , Aug. 19, 2014  Boehringer Ingelheim today ... (FDA) accepted for review the New Drug Application ... and olodaterol delivered via the Respimat ® ... maintenance treatment of airflow obstruction in patients with ... and/or emphysema. Tiotropium + olodaterol FDC will not ...
(Date:8/19/2014)... -- According to Kalorama Information, electronic medical records (EMR) ... in healthcare a reality, and this a factor that ... Recovery and Reinvestment Act, the U.S. government dedicated $20.6 ... will start applying soon for use of paper records.  ... of the EMR industry, EMR 2014: The Market ...
(Date:8/19/2014)... Calif. , Aug. 19, 2014  Cardiva Medical, ... two tranches of a $16.5 million Series 3 private ... with GE Capital. The Company will use the proceeds ... facility to expand commercial efforts for its VASCADE® Vascular ... . Investing in Series 3 private ...
Breaking Medicine Technology:Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 2Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 3Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 4Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 5Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 6Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 7Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 8Kalorama: EMR Paves the Way for Big Data 2Kalorama: EMR Paves the Way for Big Data 3Cardiva Medical, Inc. Announces Completion of the first two tranches of Series 3 Private Equity Financing and the Closing of a Senior Secured Debt Facility with GE Capital 2
... Nebulizer Prefilled 750ML Sterile H 2 O ... with sterile water for inhalation, these humidifier systems ... which makes a round opening for secure attachment ... designed to help prevent particulate from reaching oxygen ...
... 35%-100% FIO2, ,Empty Nebulizer 002002 has ... It has ports for a feed set ... 5007P and 5207 have FIO2 settings adjustable ... slip-on heaters are also available to provide ...
... , One device provides both ... from a single gas source , ... the number of SKUs dedicated to ... inconvenience of double or wye set ...
MISTY OX® Hi-Fi Nebulizer...
Medicine Products: